Avenzo Therapeutics

We’re excited to introduce the new members of #TeamAvenzo, who are eager to join us in our mission to advance a pipeline of potential best-in-class oncology therapies. Please help us in welcoming:    Nicole Doherty, Senior Director, Human Resources     Evan Pendleton, Manager, Clinical Data Management    Jana Sipes, Executive Director, Quality Assurance    Bertha P. Peele, MBA, Associate Director, Regulatory Operations    Rafa Sharhan, Senior Director, Clinical Trial Supplies    Together, we’re striving to improve patient lives. Welcome to #TeamAvenzo!     #NewHires  

Well-deserved congratulations to our Co-founder, President and CEO, Athena Countouriotis MD, for being hand-selected by Goldman Sachs as one of its Most Exceptional Entrepreneurs of 2024 this week at the Builders and Innovators Summit!      This prestigious recognition highlights her dedication to innovation and leadership, exemplified by her impressive track record of growing and scaling companies throughout her career.     Join us in congratulating Dr. Countouriotis on this incredible achievement! Learn more: https://bit.ly/4f5MCEr #GSInnovators  

We're thrilled to introduce three fantastic new members of #TeamAvenzo! Join us in giving Chris Caster, Andra Levonian Fromme, and Laura S. a warm welcome. We are proud to expand our workforce and look forward to working together to develop the next generation of #oncology therapies for patients. #NewHires  

Today, we announced the appointment of Garry Nicholson to our Board of Directors! With more than 30 years of experience in the pharmaceutical and #biotech industries, his distinguished background and deep understanding of the #oncology landscape will be invaluable as we continue to develop an innovative pipeline of potentially best-in-class therapies to fight cancers with high unmet medical needs.     Read the full press release here: https://bit.ly/4epNZ0U

Join us in welcoming our new Executive Director of Clinical Operations, Jessica Crane! With her deep expertise in oncology clinical development, her insights will be incredibly valuable as we continue to develop our pipeline of next-generation therapies for #cancer patients.  

Today at #ESMO24, we’re presenting a poster highlighting our ongoing Phase 1/2 study of our potential best-in-class selective CDK2 inhibitor, AVZO-021, in advanced solid tumors. Join us or view the poster at https://bit.ly/4e5jywD to learn more about AVZO-021’s potential as both a monotherapy and combination agent for multiple types of cancer. ESMO - European Society for Medical Oncology

A huge congratulations to our CEO & Co-Founder, Athena Countouriotis MD, who has been honored with the Director of the Year award for Corporate Governance by the Corporate Directors Forum!    Last week, Dr. Countouriotis joined the celebration of San Diego’s top directors who have made a remarkable impact on leadership. Her dedication to excellence and innovation have truly set a high standard in our industry.    Thank you to the Corporate Directors Forum for this prestigious recognition and wonderful event! 

Today, we are happy to announce our #clinicalstudy collaboration & supply agreement with Gilead Sciences to evaluate the safety and efficacy of AVZO-021, our potentially best-in-class CDK2 inhibitor, in combination with Gilead’s Trodelvy®, a Trop-2 directed antibody-drug conjugate. This combination therapy will be evaluated as part of our ongoing Phase 1/2 study for patients with HR+/HER2- metastatic #breastcancer. Learn more about the clinical study, including our plans to initiate the combination cohorts in Q4 2024 here: https://bit.ly/4dLxbAZ

We’re thrilled to introduce Bret Henning, Avenzo Therapeutics’ new Executive Director of IT and Facilities! With over 30 years of experience, he brings expertise from startup & commercial sectors in both the #lifescience and medical device industries. Learn more about Bret: https://lnkd.in/gH5H_svY #NewHire #TeamAvenzo    

We are excited to announce that Miriam Cruz has joined #TeamAvenzo as Senior Vice President of Clinical Operations! She has more than 25 years of experience in the #pharmaceutical and #biotech industries and will bring a wealth of knowledge to our team. Miriam’s expertise will be crucial as we advance clinical operations and continue to drive our pipeline forward. Please join us in welcoming Miriam to Avenzo and learn more about her background here: https://lnkd.in/gH5H_svY #NewHire